XML 44 R33.htm IDEA: XBRL DOCUMENT v3.19.2
Stockholders' Equity (Deficit) (Details Narrative) - USD ($)
6 Months Ended 12 Months Ended
Jan. 23, 2019
Jun. 30, 2019
Dec. 31, 2018
Authorized capital stock   100,000,000  
Number of common stock authorized   80,000,000 80,000,000
Common stock par value   $ 0.0001 $ 0.0001
Number of preferred stock authorized   20,000,000 20,000,000
Preferred stock par value   $ 0.0001 $ 0.0001
Preferred stock, shares issued   5,768,956 5,768,956
Preferred stock, shares outstanding   5,768,956 5,768,956
Common stock issued   70,135,036 70,135,036
Common stock outstanding   70,135,036 70,135,036
Intrinsic value of option outstanding   $ 176,975  
Intrinsic value of option exercisable   $ 76,786  
Number of option granted   2,142,500  
Exercise price per share   $ 0.41 $ 0.59
Fair value of warrants   $ 167,440  
Stock based compensation expense   187,700  
Unrecognized stock based compensation   179,300  
Total intrinsic value of warrants outstanding and exercisable   $ 833,333  
Warrants granted  
Employee and Consultants [Member]      
Number of option granted 1,442,500    
Exercise price per share $ 0.13    
Stock option exercisable term 5 years    
Stock option vesting term 2 years    
Series A Cumulative Convertible Preferred Stock [Member]      
Number of preferred stock authorized   50,000  
Preferred stock, shares issued   0  
Preferred stock, shares outstanding   0